| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Jamil Khurram is a Chief Medical Officer at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 12 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | GALT Galectin Therapeutics Inc | Chief Medical Officer | Sale+OE | 60,000 | $3.87 | $232,402.06 | -46.7% | -25.8% | - | |
| Dec 31, 2025 | GALT Galectin Therapeutics Inc | Chief Medical Officer | Sale+OE | 8,125 | $4.07 | $33,089.06 | -100% | -32.9% | - | |
| Dec 17, 2025 | GALT Galectin Therapeutics Inc | Chief Medical Officer | Sale+OE | 19,442 | $7.04 | $136,871.68 | -100% | -51.3% | - | |
| Nov 13, 2025 | GALT Galectin Therapeutics Inc | Chief Medical Officer | Sale+OE | 121,117 | $5.47 | $662,509.99 | -87.1% | -50.1% | - | |
| Dec 23, 2024 | GALT Galectin Therapeutics Inc | Chief Medical Officer | Sale+OE | 13,654 | $0.88 | $12,044.19 | -34.1% | +85.4% | +348.3% |